Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma

scientific article published on 7 July 2005

Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000086783
P698PubMed publication ID16015044

P2093author name stringHans-Peter Horny
Karl Sotlar
Ingo Kausch
Stefan Krüger
P2860cites workOne-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probesQ24685763
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumorsQ28118852
Activating c-kit gene mutations in human germ cell tumorsQ30304054
Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinomaQ34669551
Overexpression of KIT in chromophobe renal cell carcinomaQ38357715
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutationsQ40748765
Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.Q42937195
Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activityQ44222480
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epitheliumQ44544392
Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarraysQ44598886
KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.Q47708956
The Heidelberg classification of renal cell tumours.Q55067278
P433issue2-3
P921main subjectrenal cell carcinomaQ1164529
P304page(s)269-275
P577publication date2005-07-07
P1433published inOncologyQ2016300
P1476titleExpression of KIT (CD117) in renal cell carcinoma and renal oncocytoma
P478volume68

Reverse relations

cites work (P2860)
Q24625843Accurate molecular classification of renal tumors using microRNA expression
Q36477265Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma
Q37393870Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.
Q34609872Diagnostic Utility of Caveolin-1 and MOC-31 in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma
Q42428624Histological and immunohistochemical characterization of feline renal cell carcinoma: a case series
Q46091422Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.
Q37862661Metastatic chromophobe renal cell carcinoma in pleural fluid cytology: review of literature and report of a case
Q38089764Molecular diagnosis of renal cell neoplasms: the usefulness of immunohistochemistry and fluorescence in situ hybridization
Q37836508Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities
Q46770771Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma
Q34072594Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma
Q46849124Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma
Q26740953Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
Q37756379Rereading the renal cell tumors
Q37100490Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma
Q26995391Targeted therapies and the treatment of non-clear cell renal cell carcinoma
Q39010437Vimentin 3, the new hope, differentiating RCC versus oncocytoma

Search more.